)
)
While a study conducted by researchers at Banaras Hindu University (BHU) found that nearly one-third of those who received Bharat Biotech's Covid-19 vaccine Covaxin reported Adverse Events of Special Interest (AESI) after a one-year follow-up, the Hyderabad-based company cited research flaws. Watch to know more.